Jenne Kyle
SEC CIK 1791857 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IONS | IONIS PHARMACEUTICALS INC | EVP, Chf GL Pdt Str Ofcr | 23.7K | — | $3.42M | 8 | 2025-04-15 | 2026-04-16 |
Most active insiders at IONS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Monia Brett P | CEO, Dir | — | $30.35M |
| 2 | HOUGEN ELIZABETH L | EVP, CFO, Fin | — | $21.12M |
| 3 | BENNETT C FRANK | EVP, CSO | — | $16.71M |
| 4 | Geary Richard S | EVP, Chief Development Off | — | $13.35M |
| 5 | O'NEIL PATRICK R. | GC, EVP CLO | — | $9.17M |
| 6 | Devers Shannon L. | EVP, Chief Human Resources Ofc | — | $8.66M |
| 7 | Swayze Eric | EVP Research | — | $7.51M |
| 8 | LOSCALZO JOSEPH | Dir | — | $7.09M |
| 9 | KLEIN JOSEPH III | Dir | — | $6.00M |
| 10 | WENDER JOSEPH H | Dir | — | $5.44M |
| 16 | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | — | $3.33M |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-17 19:19 | 2026-04-15 | IONS | IONIS PHARMACEUTICALS INC | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | M - OptEx | $0.00 | +12.2K | 28.6K | +75% | $0 |
| D | 2026-04-17 19:19 | 2026-04-16 | IONS | IONIS PHARMACEUTICALS INC | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | S - Sale+OE | $75.17 | -4,902 | 23.7K | -17% | -$368.5K |
| DM | 2026-03-11 | 2026-03-10 | IONS | IONIS PHARMACEUTICALS INC | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | M - OptEx | $44.67 | +37.3K | 16.4K | New | +$1.67M |
| DM | 2026-03-11 | 2026-03-10 | IONS | IONIS PHARMACEUTICALS INC | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | S - Sale+OE | $75.85 | -37.3K | 27.8K | -57% | -$2.83M |
| D | 2026-01-20 | 2026-01-15 | IONS | IONIS PHARMACEUTICALS INC | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | M - OptEx | $0.00 | +7,013 | 18.2K | +63% | $0 |
| D | 2026-01-20 | 2026-01-16 | IONS | IONIS PHARMACEUTICALS INC | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | S - Sale+OE | $75.96 | -1,823 | 16.4K | -10% | -$138.5K |
| D | 2025-04-17 | 2025-04-15 | IONS | IONIS PHARMACEUTICALS INC | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | M - OptEx | $0.00 | +12.2K | 14.2K | +615% | $0 |
| D | 2025-04-17 | 2025-04-16 | IONS | IONIS PHARMACEUTICALS INC | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | S - Sale+OE | $28.36 | -3,016 | 11.2K | -21% | -$85.5K |
Purchase Sale Sale after option exercise All abbreviations